privia health group inc - PRVA

PRVA

Close Chg Chg %
23.32 -0.11 -0.45%

Open Market

23.22

-0.11 (0.45%)

Volume: 262.07K

Last Updated:

Jan 20, 2026, 3:24 PM EDT

Company Overview: privia health group inc - PRVA

PRVA Key Data

Open

$23.00

Day Range

22.77 - 23.53

52 Week Range

18.78 - 26.51

Market Cap

$2.87B

Shares Outstanding

123.00M

Public Float

114.73M

Beta

0.83

Rev. Per Employee

N/A

P/E Ratio

164.23

EPS

$0.15

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

616.85K

 

PRVA Performance

1 Week
 
0.00%
 
1 Month
 
-1.35%
 
3 Months
 
-10.27%
 
1 Year
 
4.86%
 
5 Years
 
N/A
 

PRVA Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 22
Full Ratings ➔

About privia health group inc - PRVA

Privia Health Group, Inc. engages in the provision of healthcare services. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experience, and reward doctors for delivering care both in-person and via its Privia Platform, virtual care settings. The company was founded by Jeffrey Butler on November 7, 2007 and is headquartered in Arlington, VA.

PRVA At a Glance

Privia Health Group, Inc.
950 North Globe Road
Arlington, Virginia 22203
Phone 1-571-366-8850 Revenue 1.74B
Industry Life/Health Insurance Net Income 14.39M
Sector Finance 2024 Sales Growth 4.745%
Fiscal Year-end 12 / 2025 Employees 1,140
View SEC Filings

PRVA Valuation

P/E Current 164.225
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 170.742
Price to Sales Ratio 1.414
Price to Book Ratio 3.703
Price to Cash Flow Ratio 22.47
Enterprise Value to EBITDA 83.236
Enterprise Value to Sales 1.162
Total Debt to Enterprise Value 0.003

PRVA Efficiency

Revenue/Employee 1,523,149.123
Income Per Employee 12,618.421
Receivables Turnover 5.492
Total Asset Turnover 1.612

PRVA Liquidity

Current Ratio 1.859
Quick Ratio 1.859
Cash Ratio 1.094

PRVA Profitability

Gross Margin 9.767
Operating Margin 0.978
Pretax Margin 1.605
Net Margin 0.828
Return on Assets 1.335
Return on Equity 2.404
Return on Total Capital 2.245
Return on Invested Capital 2.388

PRVA Capital Structure

Total Debt to Total Equity 0.88
Total Debt to Total Capital 0.872
Total Debt to Total Assets 0.488
Long-Term Debt to Equity 0.478
Long-Term Debt to Total Capital 0.474
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Privia Health Group Inc - PRVA

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
966.22M 1.36B 1.66B 1.74B
Sales Growth
+18.25% +40.41% +22.19% +4.74%
Cost of Goods Sold (COGS) incl D&A
905.02M 1.23B 1.50B 1.57B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
2.46M 4.57M 6.53M 7.27M
Depreciation
1.15M 1.22M 1.17M 1.10M
Amortization of Intangibles
1.31M 3.35M 5.36M 6.16M
COGS Growth
+22.91% +35.52% +22.53% +4.26%
Gross Income
61.20M 130.21M 154.97M 169.59M
Gross Income Growth
-24.20% +112.77% +19.01% +9.43%
Gross Profit Margin
+6.33% +9.60% +9.35% +9.77%
2021 2022 2023 2024 5-year trend
SG&A Expense
278.63M 149.33M 134.32M 152.60M
Research & Development
- - - -
-
Other SG&A
278.63M 149.33M 134.32M 152.60M
SGA Growth
+403.32% -46.41% -10.05% +13.61%
Other Operating Expense
- - - -
-
Unusual Expense
- - - -
-
EBIT after Unusual Expense
(217.44M) (19.12M) 20.65M 16.98M
Non Operating Income/Expense
- 542.00K 8.37M 10.89M
Non-Operating Interest Income
- 542.00K 8.37M 10.89M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - 1.07M
-
Interest Expense Growth
- - - -44.18%
-
Gross Interest Expense
- - - 1.07M
-
Interest Capitalized
- - - -
-
Pretax Income
(218.51M) (18.58M) 29.02M 27.87M
Pretax Income Growth
-1,031.28% +91.50% +256.19% -3.97%
Pretax Margin
-22.61% -1.37% +1.75% +1.61%
Income Tax
(27.86M) (6.52M) 7.99M 10.83M
Income Tax - Current - Domestic
345.00K 509.00K 528.00K 2.01M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(28.20M) (7.03M) 7.46M 8.82M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(190.65M) (12.06M) 21.03M 17.04M
Minority Interest Expense
(2.42M) (3.48M) (2.05M) 2.66M
Net Income
(188.23M) (8.59M) 23.08M 14.38M
Net Income Growth
-702.45% +95.44% +368.83% -37.67%
Net Margin Growth
-19.48% -0.63% +1.39% +0.83%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(188.23M) (8.59M) 23.08M 14.38M
Preferred Dividends
- - - -
-
Net Income Available to Common
(188.23M) (8.59M) 23.08M 14.38M
EPS (Basic)
-1.7455 -0.0776 0.1977 0.1205
EPS (Basic) Growth
-690.49% +95.55% +354.77% -39.05%
Basic Shares Outstanding
107.84M 110.70M 116.73M 119.40M
EPS (Diluted)
-1.7455 -0.0776 0.1851 0.1145
EPS (Diluted) Growth
-690.49% +95.55% +338.53% -38.14%
Diluted Shares Outstanding
107.84M 110.70M 124.69M 125.61M
EBITDA
(214.97M) (14.55M) 27.18M 24.25M
EBITDA Growth
-889.67% +93.23% +286.81% -10.79%
EBITDA Margin
-22.25% -1.07% +1.64% +1.40%

Snapshot

Average Recommendation BUY Average Target Price 31.476
Number of Ratings 22 Current Quarters Estimate 0.079
FY Report Date 03 / 2026 Current Year's Estimate 0.316
Last Quarter’s Earnings 0.035 Median PE on CY Estimate N/A
Year Ago Earnings 0.132 Next Fiscal Year Estimate 0.423
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 12 12 14 9
Mean Estimate 0.08 0.09 0.32 0.42
High Estimates 0.27 0.28 0.43 0.58
Low Estimate 0.01 0.03 0.14 0.22
Coefficient of Variance 83.16 67.61 23.06 24.05

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 19 18 17
OVERWEIGHT 1 1 1
HOLD 2 2 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Privia Health Group Inc - PRVA

Date Name Shares Transaction Value
Jul 18, 2025 Lance V. Berberian Director 7,668 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 David Mountcastle EVP & Chief Financial Officer 179,676 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $22.38 per share 4,021,148.88
Mar 17, 2025 Parth Mehrotra Chief Executive Officer; Director 469,381 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $24.03 per share 11,279,225.43
Mar 7, 2025 Edward Christopher Fargis EVP & General Counsel 98,021 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Privia Health Group Inc in the News